Telemark Asset Management LLC Cuts Stock Holdings in ASP Isotopes Inc. $ASPI

Telemark Asset Management LLC decreased its holdings in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 37.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 825,000 shares of the company’s stock after selling 500,000 shares during the period. Telemark Asset Management LLC owned 0.74% of ASP Isotopes worth $4,414,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of ASPI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of ASP Isotopes by 9.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock valued at $148,000 after buying an additional 2,709 shares in the last quarter. Rhumbline Advisers boosted its holdings in shares of ASP Isotopes by 20.9% in the 2nd quarter. Rhumbline Advisers now owns 78,994 shares of the company’s stock valued at $581,000 after buying an additional 13,668 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of ASP Isotopes in the 2nd quarter valued at about $178,000. New York State Common Retirement Fund boosted its holdings in shares of ASP Isotopes by 418.2% in the 2nd quarter. New York State Common Retirement Fund now owns 17,100 shares of the company’s stock valued at $126,000 after buying an additional 13,800 shares in the last quarter. Finally, Invesco Ltd. boosted its holdings in shares of ASP Isotopes by 2,205.0% in the 2nd quarter. Invesco Ltd. now owns 471,219 shares of the company’s stock valued at $3,468,000 after buying an additional 450,776 shares in the last quarter. 16.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ASPI has been the topic of a number of recent analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a report on Friday, March 27th. Canaccord Genuity Group restated a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, ASP Isotopes presently has an average rating of “Hold” and a consensus target price of $13.00.

ASP Isotopes Stock Down 15.8%

NASDAQ:ASPI opened at $6.71 on Friday. ASP Isotopes Inc. has a fifty-two week low of $3.92 and a fifty-two week high of $14.49. The stock has a market capitalization of $844.79 million, a P/E ratio of -3.23 and a beta of 3.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 4.37 and a current ratio of 4.39. The company’s 50-day simple moving average is $5.54 and its 200-day simple moving average is $5.87.

ASP Isotopes (NASDAQ:ASPI) last released its earnings results on Wednesday, May 20th. The company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.06. The company had revenue of $8.36 million during the quarter, compared to analysts’ expectations of $3.68 million. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

Insider Activity at ASP Isotopes

In related news, CFO Heather Kiessling sold 23,124 shares of ASP Isotopes stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $5.48, for a total value of $126,719.52. Following the completion of the sale, the chief financial officer directly owned 709,376 shares in the company, valued at $3,887,380.48. This trade represents a 3.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Duncan Moore sold 11,642 shares of ASP Isotopes stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $5.21, for a total transaction of $60,654.82. Following the completion of the sale, the director owned 1,044,928 shares of the company’s stock, valued at $5,444,074.88. This trade represents a 1.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 224,783 shares of company stock valued at $1,648,923 over the last 90 days. Company insiders own 14.40% of the company’s stock.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.